Monday, July 05, 2021 12:36:49 PM
It's about time for Congress and the Senate to start questioning the FDA about holding down smaller biotechs like SRNE and protecting market share for Big Pharma in an open and free economy that's supposed to have a level playing field. Although big pharma moved quickly to create vaccines and test kits (for a profilt!) in project warp speed, that shouldn't negativelly affect the scientific advancements of other smaller biotechs. SRNE has proven to have superior test products and we have nothing but radio silence from the FDA on the product. Even Mexico has approved it! The DoD is on board. The Mayo Clinic is on board. When are we going to hear someone from Washington DC ask about SRNE? California, this is your state! Where are your representatives? Why aren't they beating down the doors of the FDA to get fair treatment for this (eventual) multi-billion dollar company? Reply: Lucifercrv: The biggest problem with your idea is that many Congressmen are already on Big Pharma's payroll so they won't do squat to inhibit BP. The system is completely broken and the foxes are now guarding the henhouse.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM